BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32991522)

  • 1. Brain-derived neurotrophic factor Val66Met polymorphism affects cortical thickness of rostral anterior cingulate in patients with major depressive disorder.
    Shen Z; Lu Y; Jiang H; Ye J; Zhou C; He M; Li N; Xu X; Cheng Y
    Neuroreport; 2020 Nov; 31(16):1146-1153. PubMed ID: 32991522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.
    Colle R; Trabado S; David DJ; Brailly-Tabard S; Hardy P; Falissard B; Fève B; Becquemont L; Verstuyft C; Corruble E
    Neuropsychobiology; 2017; 75(1):39-45. PubMed ID: 28848102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
    Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
    Neuropsychobiology; 2010; 61(2):71-8. PubMed ID: 20016225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study.
    Jaworska N; MacMaster FP; Foster J; Ramasubbu R
    BMC Psychiatry; 2016 Mar; 16():61. PubMed ID: 26976307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI.
    Ide S; Kakeda S; Watanabe K; Yoshimura R; Abe O; Hayashi K; Ueda I; Kishi T; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J; Korogi Y
    Psychiatry Res; 2015 Aug; 233(2):120-4. PubMed ID: 26078197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cortical thickness with age of onset in first-episode, drug-naïve major depression.
    Shen Z; Jiang H; Cheng Y; Ye J; Lu Y; Zhou C; Li N; Dai N; He M; Xu X
    Neuroreport; 2019 Nov; 30(16):1074-1080. PubMed ID: 31503209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder.
    Legge RM; Sendi S; Cole JH; Cohen-Woods S; Costafreda SG; Simmons A; Farmer AE; Aitchison KJ; McGuffin P; Fu CH
    Br J Psychiatry; 2015 May; 206(5):379-84. PubMed ID: 25745134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF Val66Met polymorphism in patterns of neural activation in individuals with MDD and healthy controls.
    Lisiecka DM; O'Hanlon E; Fagan AJ; Carballedo A; Morris D; Suckling J; Frodl T
    J Affect Disord; 2015 Sep; 184():239-44. PubMed ID: 26117067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Val66Met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome.
    Cardoner N; Soria V; Gratacòs M; Hernández-Ribas R; Pujol J; López-Solà M; Deus J; Urretavizcaya M; Estivill X; Menchón JM; Soriano-Mas C
    Depress Anxiety; 2013 Mar; 30(3):225-33. PubMed ID: 23165919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder.
    Na KS; Won E; Kang J; Chang HS; Yoon HK; Tae WS; Kim YK; Lee MS; Joe SH; Kim H; Ham BJ
    Sci Rep; 2016 Feb; 6():21089. PubMed ID: 26876488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults.
    Yang X; Liu P; Sun J; Wang G; Zeng F; Yuan K; Liu J; Dong M; von Deneen KM; Qin W; Tian J
    PLoS One; 2012; 7(6):e37777. PubMed ID: 22719849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
    Katsuki A; Yoshimura R; Kishi T; Hori H; Umene-Nakano W; Ikenouchi-Sugita A; Hayashi K; Atake K; Iwata N; Nakamura J
    CNS Spectr; 2012 Sep; 17(3):155-63. PubMed ID: 22883353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
    Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
    Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype.
    Carballedo A; Amico F; Ugwu I; Fagan AJ; Fahey C; Morris D; Meaney JF; Leemans A; Frodl T
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jul; 159B(5):537-48. PubMed ID: 22585743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.
    Kanellopoulos D; Gunning FM; Morimoto SS; Hoptman MJ; Murphy CF; Kelly RE; Glatt C; Lim KO; Alexopoulos GS
    Am J Geriatr Psychiatry; 2011 Jan; 19(1):13-22. PubMed ID: 21218562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of 5-HTTLPR and BDNF Val66Met polymorphisms on neurostructural changes in major depressive disorder.
    Han KM; Choi S; Kim A; Kang J; Won E; Tae WS; Kim YK; Lee MS; Ham BJ
    Psychiatry Res Neuroimaging; 2018 Mar; 273():25-34. PubMed ID: 29414128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression.
    Caldieraro MA; McKee M; Leistner-Segal S; Vares EA; Kubaski F; Spanemberg L; Brusius-Facchin AC; Fleck MP; Mischoulon D
    World J Biol Psychiatry; 2018 Aug; 19(5):402-409. PubMed ID: 28656803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF-Dependent Effects on Amygdala-Cortical Circuitry and Depression Risk in Children and Youth.
    Wheeler AL; Felsky D; Viviano JD; Stojanovski S; Ameis SH; Szatmari P; Lerch JP; Chakravarty MM; Voineskos AN
    Cereb Cortex; 2018 May; 28(5):1760-1770. PubMed ID: 28387866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.